Take Solutions Limited
Healthcare›Healthcare›Healthcare Services›Healthcare Research, Analytics & Technology
Key metrics
Price as of 2026-07-20
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Only consolidated filings are available for this company — standalone cannot be selected.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 189 Cr | 17 Cr | 36 Cr | 52 Cr | 66 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 54 Cr |
| Operating expenses (approx.) | 210 Cr | 19 Cr | 35 Cr | 50 Cr | 171 Cr | 2 Cr | 3 Cr | -6 Cr | 0.73 Cr | 0.29 Cr | -1 Cr | 50 Cr |
| EBITDA | -21 Cr | -1 Cr | 0.67 Cr | 3 Cr | -105 Cr | -2 Cr | -3 Cr | 6 Cr | -0.73 Cr | -0.29 Cr | 1 Cr | 4 Cr |
| OPM % | -11.1% | -7.3% | 1.9% | 5.5% | -160.2% | — | — | — | — | — | — | 8.1% |
| Other income | 8 Cr | 0.28 Cr | 0.42 Cr | 2 Cr | 2 Cr | 0.0000 Cr | 0.0000 Cr | 9 Cr | 0.04 Cr | 0.0000 Cr | 1 Cr | 5 Cr |
| Interest | 7 Cr | 2 Cr | 3 Cr | 4 Cr | 5 Cr | 0.49 Cr | 0.99 Cr | 0.73 Cr | 0.17 Cr | 0.17 Cr | 0.0009 Cr | 0.0000 Cr |
| Depreciation | 17 Cr | 2 Cr | 4 Cr | 6 Cr | 8 Cr | 0.01 Cr | 0.02 Cr | 0.01 Cr | 0.0020 Cr | 0.0020 Cr | 0.0020 Cr | 0.0020 Cr |
| Profit before tax | -45 Cr | -5 Cr | -7 Cr | -8 Cr | -118 Cr | -3 Cr | -4 Cr | 5 Cr | -0.91 Cr | -0.47 Cr | 1 Cr | 4 Cr |
| Tax % | -3.7% | -5.1% | -3.0% | -18.1% | -1.0% | -2.1% | 0.0% | 0.0% | 0.0% | -34.2% | 0.0% | 0.0% |
| Net profit | -100 Cr | -5 Cr | -7 Cr | -9 Cr | -120 Cr | -4 Cr | -5 Cr | 48 Cr | -0.91 Cr | 6 Cr | 1 Cr | 4 Cr |
| EPS (₹) | ₹-6.86 | ₹-0.36 | ₹-0.47 | ₹-0.62 | ₹-8.18 | ₹-0.26 | ₹-0.37 | ₹3.26 | ₹-0.06 | ₹0.43 | ₹0.07 | ₹0.29 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Sales | 2,213 Cr | 774 Cr | 655 Cr | 0.0000 Cr | 54 Cr | Sign in for TTM |
| Operating expenses (approx.) | 2,018 Cr | 1,060 Cr | 631 Cr | -3 Cr | 49 Cr | Sign in for TTM |
| EBITDA | 195 Cr | -286 Cr | 24 Cr | 3 Cr | 5 Cr | Sign in for TTM |
| OPM % | 8.8% | -37.0% | 3.6% | — | 8.8% | Sign in for TTM |
| Other income | 26 Cr | 12 Cr | 17 Cr | 10 Cr | 7 Cr | Sign in for TTM |
| Interest | 41 Cr | 37 Cr | 29 Cr | 2 Cr | 0.35 Cr | Sign in for TTM |
| Depreciation | 167 Cr | 115 Cr | 80 Cr | 0.04 Cr | 0.0081 Cr | Sign in for TTM |
| Profit before tax | -13 Cr | -439 Cr | -85 Cr | 0.74 Cr | 4 Cr | Sign in for TTM |
| Tax % | 15.3% | -3.1% | -4.2% | 0.0% | 3.6% | Sign in for TTM |
| Net profit | -11 Cr | -450 Cr | -782 Cr | 37 Cr | 11 Cr | Sign in for TTM |
| EPS (₹) | ₹-0.85 | ₹-30.91 | ₹-53.50 | ₹2.56 | ₹0.74 | Sign in for TTM |
| Dividend payout % | — | — | — | 0.1% | 0.0% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | 15 Cr | 15 Cr | 15 Cr | 15 Cr | 15 Cr |
| Reserves | 0.0000 Cr | 0.0000 Cr | 0.0000 Cr | 6 Cr | 16 Cr |
| Borrowings | — | — | — | — | — |
| Other liabilities | — | — | — | 16 Cr | 5 Cr |
| Total liabilities | — | — | — | 36 Cr | 36 Cr |
| Fixed assets (net) | — | — | — | 0.0000 Cr | 0.0000 Cr |
| CWIP | — | — | — | 0.0000 Cr | — |
| Investments | — | — | — | 0.0000 Cr | 0.0000 Cr |
| Other assets | — | — | — | 24 Cr | 24 Cr |
| Total assets | — | — | — | 36 Cr | 36 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operating activity | — | — | 30 Cr | -16 Cr | -4 Cr |
| Cash from investing | — | — | -31 Cr | 22 Cr | 2 Cr |
| Cash from financing | — | — | -55 Cr | -3 Cr | -0.72 Cr |
| Net cash flow | — | — | -56 Cr | 3 Cr | -3 Cr |
| Free cash flow (OCF − Capex) | — | — | -2 Cr | -16 Cr | -4 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| ROCE % | 194.1% | -2745.7% | -382.7% | 13.1% | 15.4% |
| ROE % | 492.7% | -3077.9% | -5349.7% | 182.5% | 35.0% |
| Debtor days | — | — | — | — | — |
| Inventory days | — | — | — | — | 0 |
| Days payable | — | — | — | — | — |
| Cash conversion cycle | — | — | — | — | 0 |
| Debt / equity | — | — | — | — | — |
| Current ratio | — | — | — | 1.48 | 4.54 |
| Net debt / EBITDA | 0.00 | — | 0.00 | -1.23 | -0.05 |
Compare with peers
Loading peers…